Anesth Analg 2002;94:729-731
© 2002 International Anesthesia Research Society
REGIONAL ANESTHESIA
Bacterial Growth in Ropivacaine Hydrochloride
Istvan Bátai, PhD*,
Monika Kerényi, MD ,
Judit Falvai*, and
Gyorgy Szabó, PhD
*Department of Anesthesia and Intensive Care, Department of Clinical Microbiology, Department of Orthopedic Surgery, University of Pécs, Pécs, Hungary
Address correspondence to Istvan Bátai, PhD, University of Pécs, Department of Anaesthesia and Intensive Care, Pécs, Szigeti u. 12., H-7624 Hungary. Address e-mail to ibatai{at}freemail.hu
IMPLICATIONS: Drugs affecting bacterial growth may influence the occurrence of postoperative infections. Ropivacaine 10 mg/mL killed Staphylococcus aureus and Escherichia coli; ropivacaine 2 mg/mL supported the growth of E. coli.
This article has been cited by other articles:

|
 |

|
 |
 
E. Boselli, M. Guillier, J. Freney, M.-A. Mazoyer, E. Casoli, F. R. N. Renaud, T. Rimmele, D. Chassard, and B. Allaouchiche
Antibacterial Activity of Clonidine and Neostigmine In Vitro
Anesth. Analg.,
July 1, 2005;
101(1):
121 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kampe, C. Poetter, S. Buzello, H.-M. Wenchel, M. Paul, P. Kiencke, and S.-M. Kasper
Ropivacaine 0.1% with Sufentanil 1 {micro}g/mL Inhibits In Vitro Growth of Pseudomonas Aeruginosa and Does Not Promote Multiplication of Staphylococcus Aureus
Anesth. Analg.,
August 1, 2003;
97(2):
409 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|